4.8 Editorial Material

Accelerating the development of therapeutic strategies for drug-resistant tuberculosis

Journal

NATURE REVIEWS DRUG DISCOVERY
Volume 17, Issue 9, Pages 607-608

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrd.2018.28

Keywords

-

Funding

  1. National Institute for Health Research (NIHR) Biomedical Research Centre at University College London Hospitals NHS Foundation Trust
  2. NIHR Senior Investigator Award
  3. US Centers for Disease Control and Prevention TB Trials Consortium
  4. National Institute of Allergy and Infectious Diseases, US National Institutes of Health

Ask authors/readers for more resources

Recent progress in the discovery, development and evaluation of new drugs and combination regimens for drug-resistant tuberculosis through greater collaboration between industry, donors and academia provides renewed hope for overcoming the challenges in tuberculosis treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available